comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 22:16:21 - browse：78

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Medicare Advantage today, explained in one chart

knowledge

Wikipedia

WSS

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Independent physicians launch a new lobbying group

Has Bernie Sanders reached the limit of his pharma bullying effort?

NIH director takes cautious approach to Biden drug pricing priority

The tragedy of Johnson & Johnson’s Covid vaccine

BIO to announce reorganization, senior leaders expected to depart

leisure time

comprehensive

focus

The cancer drug shortage isn’t new — and neither are the solutions

The surgeon had a dilemma only a Nazi medical text could resolve

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New brain studies show LSD's effects on the brain in full color

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

AI for drug discovery: Experts on separating hype from reality

Peter Hotez and the public health issue of online harassment

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

explore

PBM executives asked to testify by House panel

PBM executives asked to testify by House panel

Most antidepressants don't work on kids, teens, study finds

Independent physicians launch a new lobbying group

Novel spinal cord stimulator treats paralysis without surgery

Can gargling with Listerine treat gonorrhea of the mouth?

knowledge

Wikipedia

entertainment

focus